major depressive disorder
Showing NaN - NaN of 86
MDD Trial in United States (Vortioxetine, Placebo)
MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)
Completed
- Major Depressive Disorder
- Agomelatine (AGO178C)
- Placebo
-
Birmingham, Alabama
- +47 more
Dec 15, 2020
MDD Trial in Puerto Rico, United States (Placebo, Levomilnacipran, Fluoxetine)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Dothan, Alabama
- +48 more
Aug 19, 2020
MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))
Completed
- Major Depressive Disorder
- Assay-guided treatment (AGT)
- Treatment-as-usual (TAU)
-
Birmingham, Alabama
- +22 more
Aug 27, 2020
MDD Trial in United States (TS-121 10 mg, TS-121 50 mg, Placebo)
Terminated
- Major Depressive Disorder
- TS-121 10 mg
- +2 more
-
Little Rock, Arkansas
- +21 more
Jul 1, 2020
Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Depression
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Beverly Hills, California
- +34 more
Dec 23, 2019
MDD Trial in United States (Placebo, Vilazodone)
MDD Trial in Canada, United States (Vilazodone)
Completed
- Major Depressive Disorder
-
Birmingham, Alabama
- +55 more
Sep 10, 2019
MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))
Completed
- Major Depressive Disorder
- Cariprazine
- Antidepressant Therapy (ADT)
-
Tucson, Arizona
- +89 more
Jul 29, 2019
MDD Trial in Australia, Canada, United States (High Dose ALKS 5461, Low Dose ALKS 5461, Placebo)
Completed
- Major Depressive Disorder
- High Dose ALKS 5461
- +2 more
-
Birmingham, Alabama
- +48 more
Aug 2, 2019
MDD Trial in United States (Vortioxetine)
Completed
- Major Depressive Disorder
-
Costa Mesa, California
- +24 more
Jun 14, 2019
MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )
Completed
- Major Depressive Disorder
- desvenlafaxine succinate sustained release
- +2 more
-
Dothan, Alabama
- +42 more
Jan 2, 2019
MDD Trial in Worldwide (ALKS 5461)
Completed
- Major Depressive Disorder
- ALKS 5461
-
Birmingham, Alabama
- +157 more
Nov 21, 2018
MDD Trial in National City, Orlando (Placebo, Brexpiprazole 1 mg, Brexpiprazole 3 mg)
Terminated
- Major Depressive Disorder
- Placebo
- +2 more
-
National City, California
- +1 more
Sep 18, 2018
MDD Trial in Worldwide (Placebo, Cariprazine)
Completed
- Major Depressive Disorder
- Placebo
- Cariprazine
-
Garden Grove, California
- +71 more
Mar 29, 2018
MDD Trial in Worldwide (LY2216684, Placebo, SSRI)
Completed
- Major Depressive Disorder
- LY2216684
- +2 more
-
Garden Grove, California
- +48 more
Mar 26, 2018
MDD Trial in Romania, United States (LY2216684, Placebo, Escitalopram)
MDD Trial in United States (vilazodone)
Completed
- Major Depressive Disorder
-
Garden Grove, California
- +37 more
Aug 22, 2017
MDD Trial in Worldwide (AZD6765 iv, Placebo)
Completed
- Major Depressive Disorder
- AZD6765 iv
- Placebo
-
Chino, California
- +43 more
Apr 10, 2017
MDD Trial in Chile, Mexico, United States (Desvenlafaxine Succinate Sustained-Release, Placebo)
Completed
- Major Depressive Disorder
- Desvenlafaxine Succinate Sustained-Release
- Placebo
-
Birmingham, Alabama
- +41 more
Jan 30, 2017